Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

779 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Linkage exclusion in French families with probable Parkinson' s disease.
Farrer M, Destée T, Becquet E, Wavrant-De Vrièze F, Mouroux V, Richard F, Defebvre L, Lincoln S, Hardy J, Amouyel P, Chartier-Harlin MC. Farrer M, et al. Among authors: amouyel p. Mov Disord. 2000 Nov;15(6):1075-83. doi: 10.1002/1531-8257(200011)15:6<1075::aid-mds1004>3.0.co;2-2. Mov Disord. 2000. PMID: 11104189
Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.
Lambert JC, Berr C, Pasquier F, Delacourte A, Frigard B, Cottel D, Pérez-Tur J, Mouroux V, Mohr M, Cécyre D, Galasko D, Lendon C, Poirier J, Hardy J, Mann D, Amouyel P, Chartier-Harlin MC. Lambert JC, et al. Among authors: amouyel p. Hum Mol Genet. 1998 Sep;7(9):1511-6. doi: 10.1093/hmg/7.9.1511. Hum Mol Genet. 1998. PMID: 9700208
No pathogenic mutations in the persyn gene in Parkinson's disease.
Lincoln S, Gwinn-Hardy K, Goudreau J, Chartier-Harlin MC, Baker M, Mouroux V, Richard F, Destée A, Becquet E, Amouyel P, Lynch T, Hardy J, Farrer M. Lincoln S, et al. Among authors: amouyel p. Neurosci Lett. 1999 Jan 4;259(1):65-6. doi: 10.1016/s0304-3940(98)00901-x. Neurosci Lett. 1999. PMID: 10027558
No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease.
Wavrant-DeVrièze F, Rudrasingham V, Lambert JC, Chakraverty S, Kehoe P, Crook R, Amouyel P, Wu W, Holmans P, Rice F, Pérez-Tur J, Frigard B, Morris JC, Carty S, Cottel D, Tunstall N, Lovestone S, Petersen RC, Chartier-Harlin MC, Goate A, Owen MJ, Williams J, Hardy J. Wavrant-DeVrièze F, et al. Among authors: amouyel p. Neurosci Lett. 1999 Mar 5;262(2):137-9. doi: 10.1016/s0304-3940(99)00035-x. Neurosci Lett. 1999. PMID: 10203250
Alpha-2 macroglobulin gene and Alzheimer disease.
Rudrasingham V, Wavrant-De Vrièze F, Lambert JC, Chakraverty S, Kehoe P, Crook R, Amouyel P, Wu W, Rice F, Pérez-Tur J, Frigard B, Morris JC, Carty S, Petersen R, Cottel D, Tunstall N, Holmans P, Lovestone S, Chartier-Harlin MC, Goate A, Hardy J, Owen MJ, Williams J. Rudrasingham V, et al. Among authors: amouyel p. Nat Genet. 1999 May;22(1):17-9; author reply 21-2. doi: 10.1038/8726. Nat Genet. 1999. PMID: 10319854 No abstract available.
779 results